474020-77-4 Usage
Uses
Used in Organic Synthesis:
3-amino-N,N-diethyl-4-nitrobenzamide is used as a reagent in organic synthesis for the production of various organic compounds. Its unique structure allows for versatile chemical reactions, making it a valuable component in the synthesis of a wide range of molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-amino-N,N-diethyl-4-nitrobenzamide is used as an intermediate in the production of various pharmaceuticals. Its presence in the synthesis process contributes to the development of new drugs and medicines.
Used in Medicinal Chemistry:
3-amino-N,N-diethyl-4-nitrobenzamide is used as a structural component in medicinal chemistry. Its unique arrangement of functional groups allows for the exploration of new chemical pathways and interactions, which can lead to the discovery of novel therapeutic agents.
Used in Drug Development:
Due to its potential applications in medicinal chemistry, 3-amino-N,N-diethyl-4-nitrobenzamide is also used in drug development. Its structural properties make it a promising candidate for the design and development of new pharmaceuticals with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 474020-77-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,4,0,2 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 474020-77:
(8*4)+(7*7)+(6*4)+(5*0)+(4*2)+(3*0)+(2*7)+(1*7)=134
134 % 10 = 4
So 474020-77-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H15N3O3/c1-3-13(4-2)11(15)8-5-6-10(14(16)17)9(12)7-8/h5-7H,3-4,12H2,1-2H3
474020-77-4Relevant articles and documents
Novel benzimidazole derivatives as selective CB2 agonists
Pagé, Daniel,Balaux, Elise,Boisvert, Luc,Liu, Ziping,Milburn, Claire,Tremblay, Maxime,Wei, Zhongyong,Woo, Simon,Luo, Xuehong,Cheng, Yun-Xing,Yang, Hua,Srivastava, Sanjay,Zhou, Fei,Brown, William,Tomaszewski, Miroslaw,Walpole, Christopher,Hodzic, Leila,St-Onge, Stéphane,Godbout, Claude,Salois, Dominic,Payza, Keymal
scheme or table, p. 3695 - 3700 (2009/04/04)
The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.
BENZIMIDAZOLES AND IMIDAZOPYRIDINES USEFUL IN THE TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH CANNABINOID RECEPTOR 2 (CB2) SUCH AS PAIN
-
Page/Page column 50; 77, (2008/06/13)
This invention relates to novel benzimidazoles and imidazopyridines having the structural of formula I below and their pharmaceutically acceptable salts, tautomers or in vivo -hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide treatments of CB2 associated disorders.
